Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9N56
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,448
Award facts
- Contract value 100% obligated
- $33,447.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,447.58 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price, non-set-aside delivery order represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. Dupixent is a specialty biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, reflecting the Defense Health Agency's procurement of specialized pharmaceutical products to support military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs. The company's extensive contract portfolio with DLA encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order is one of numerous transactions executed under the larger IDC vehicle, demonstrating AmerisourceBergen's continued capability to fulfill federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F9N56?
SPE2DR26F9N56 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F9N56 worth?
The government has obligated $33,448 on SPE2DR26F9N56.
Is contract SPE2DR26F9N56 an order under another contract?
Yes. SPE2DR26F9N56 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9N56 competed?
The extent of competition for SPE2DR26F9N56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award